Lieber, Carolin M.
Cox, Robert M. http://orcid.org/0000-0003-0620-1674
Sourimant, Julien http://orcid.org/0000-0002-1660-1666
Wolf, Josef D. http://orcid.org/0000-0003-2507-6944
Juergens, Kate
Phung, Quynh
Saindane, Manohar T.
Smith, Meghan K. http://orcid.org/0000-0001-8491-3824
Sticher, Zachary M. http://orcid.org/0000-0002-7022-1410
Kalykhalov, Alexander A.
Natchus, Michael G.
Painter, George R.
Sakamoto, Kaori
Greninger, Alexander L.
Plemper, Richard K. http://orcid.org/0000-0003-2034-2107
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI071002, AI141222)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 1 March 2022
Accepted: 14 July 2022
First Online: 29 July 2022
Competing interests
: M.G.N. and G.R.P. are coinventors on patent 20190022116, N<sup>4</sup>-Hydroxycytidine and derivatives and anti-viral uses related thereto, covering composition of matter and method of use of EIDD-2801 for antiviral therapy. This study could affect their personal financial status. All other authors declare no competing interests.